Navigation Links
term in Biological Technology

Neurim Pharmaceuticals Reports Long Term Efficacy and Safety for Circadin(R) for Insomnia in Elderly Patients

... release melatonin in insomnia, demonstrating long term efficacy and safety in elderly patients. The ... previously shown to be a unique short term treatment for poor sleep quality, has now demonstrated long term efficacy and safety." About Circadin(R) ...

Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation

... The distribution agreement has a term on a country-by-country and product-by-product ... to collaboration expenses. This term of the agreement will expire on a collaboration ... rate of 10%, compounded quarterly and have a term of two years. Angiotech may, at its sole ...

China Biologic Products Announces Strong First Quarter 2009 Results

... 29,300 29,340 Short term loans - bank 7,720,550 -- Short term loan - holder of noncontrolling interest ... 5,211,498 4,060,010 Long term bank loan-current maturities 439,500 ...

Tiens Biotech Group (USA) Reports First Quarter Results

... further implementing our strategic plans for long term growth." About Tiens Biotech Group (USA), ... 6,373,900 Current portion of long term debt, related party ... 33,684,857 NON-CURRENT LIABILITIES Long term debt, net of current portion, related party ...

Solutia Reports First Quarter 2009 Results

... German subsidiary obtains $74 million term loan ST. LOUIS, May 6 /PRNewswire-FirstCall/ ... million - $100 million New term Loan On May 5, 2009, a Solutia wholly owned ... into a $74 million, two-year senior unsecured term loan facility. The proceeds were used to pay ...

Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009

... First Quarter Highlights New Senior Secured term Loan and Credit Facilities. In March 2009 we announced that we had obtained a new senior secured term loan and revolving credit facility. Wells Fargo ... administrative agent and lender for both the term loan and revolving credit facility. This ...

China Biologic Products Announces Strong 2008 Results

... 955,874 711,459 Long term prepayment - related party ... 29,340 -- Short term loans - bank -- 685,500 Short term loan - minority shareholder ...

Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008

... The financing includes a delayed draw secured term loan facility of up to $10 million, and a secured ... conditions. Any borrowings outstanding under the term loan and revolving credit facility bear interest ... with a minimum Base LIBOR Rate of 2.25%. The term loan and the revolving credit facility include ...

Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008

... an exercise price equal to $2.00 per share with a term expiring 30 months after the date of the closing ... an exercise price equal to $1.25 per share with a term expiring 15 months after the closing (the ... exercise price equal to $12.50 per share with a term expiring 15 months after the closing (the ...

ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results

... 1 929 2 220 Other long term assets 1 664 ... 1 151 1 057 Other short term assets 1 422 ... - 0 Deferred income, short term (240) (375) ...

Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities

... announced it has obtained a new Senior Secured term Loan and Revolving Credit Facility. Wells Fargo ... administrative agent and lender for both the term Loan and Revolving Credit Facility. The financing includes a delayed draw secured term loan facility of up to $10 million, and a secured ...

Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results

... 10,767,780 10,942,500 Short term loans 23,266,620 ... 50,751,751 51,904,264 LONG term LIABILITIES: Capital lease obligation, net ... 1,859,323 2,653,995 Total long term liabilities 6,935,378 ...

Benda Pharmaceutical Reports Third Quarter 2008 Financial Results

... 2,976,792 2,867,004 Long term debt payable (current portion) ... 26,154,473 18,590,891 Long term debt payable (long term portion) -- ...

China Biologic Products Reports Strong Third Quarter 2008 Results

... 15,434,124 OTHER ASSETS: Long term prepayments 2,415,631 711,459 Long term prepayment - related party 551,112 ... $2,931,432 $2,677,587 Short term loans - bank -- ...

Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2008 Results and Announces Share Repurchase

... pledged bank deposits), and short term investments of RMB831.3 million (US$122.4 ... Liabilities Current liabilities Short term bank loans and borrowings 29,000 19,000 ... 342,637 387,249 57,034 Long term loan 52,000 ...

VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007

... of Fully Taxed EPS as a long term measure of growth in earnings on a comparable ... related expenditures to support new long term business initiatives in domestic and ... disclosure of Fully Taxed EPS as a long term measure of growth in earnings on a comparable ...

Favrille Announces Execution of Non-binding Term Sheet for a Merger Transaction

... today that it has entered into a non-binding term sheet for a reverse merger whereby Favrille would ... on the terms set forth in the non-binding term sheet, at the effective time of the merger, the ... plan that is outlined in the non-binding term sheet with MMR, is a condition to the signing of ...

China Biologic Products Reports Second Quarter 2008 Results

... Company (the "Independent Directors"), as that term is defined by Rule 4200(a)(15) of the Marketplace ... 791,014 711,459 Long term prepayment - related party ... $2,546,739 $2,677,587 Short term loans - bank -- ...

China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results

... the rising demand for bio-diesel. Over the long term we are confident that our diversified portfolio ... 1,457,938 1,370,877 Long term notes payable - current portion ... 10,701,520 5,476,256 LONG term NOTES PAYABLE 14,642 ...

Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results

... -- 4,902,629 Current portion of long term debt, related party ... 32,744,760 NON-CURRENT LIABILITIES Long term debt, net of current portion, related party ... 7,400,000 (843,115) Payments on long term debt, related party ...

SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results

... that our cash, cash equivalents and short- term investments will be sufficient to fund our ... 1,000,000 - Current portion of term loan 83,858 80,047 ... 1,769,134 1,424,316 Long-term portion of term loan 68,216 111,119 ...

Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.

... and we expect to benefit from both its near term revenues and long term growth. The recent EU approval of Jerini's orphan ... of 2007 which supports delivery of our long term strategy. Shire is in line to deliver another set ...

Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests

... Rosetta Genomics has Signed a Binding term Sheet to Acquire Parkway Clinical Laboratories ... announced today that it has signed a binding term sheet to acquire Parkway Clinical Laboratories ... laboratory in Lakewood, New Jersey. During his term as LPA President and CEO, the company's ...

China Biologic Products Reports First Quarter 2008 Results

... 850,130 711,459 Long term prepayment - related party 537,928 ... $ 2,471,482 $ 2,677,587 Short term loans - bank 685,500 Short term loan - minority shareholder 752,720 ...

PharmAthene Reports First Quarter 2008 Financial Results

... 38,540,357 58,474,645 Long term restricted cash 15,000,000 ... 1,221,809 1,312,991 Other long term assets 183,588 ... 3,602,886 Current portion of long term debt 4,000,000 4,000,000 Total ...

Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance

... 48,540 Deferred income tax - short term 8,137 8,825 Prepaid ... 18,621 18,621 Deferred income tax - long term 7,942 7,942 ... 13,957 846 Deferred revenue - short term 2,957 2,836 Total ...

China Bio Energy Reports Fiscal 2007 Financial Results

... 1,370,877 1,019,231 Long term notes payable - current portion ... 5,476,256 6,014,182 LONG term LIABILITIES 33,655 ... (738) (12,790) Repayment of short term loan (1,577,744) ...

PharmAthene Reports Year-End 2007 Financial Results

... 1,312,991 1,246,236 Other long term assets 183,588 ... - 11,768,089 Current portion of long term debt 4,000,000 - Total ... 374,040 - Long term debt 16,668,458 ...

Shire plc: IFRS Results for the Year Ending December 31, 2007

... which was partly funded by US$1.3 billion of term loans, utilised under Shire's US$2.3 billion banking facility (see Note 8). These term loans were subsequently partially repaid using ... in May 2007. The remaining US$200 million of the term loans was also repaid during the year to December ...

ExonHit Therapeutics - 2007 Financial Results

... aims at ensuring the coherence and the long term objectives of the Company. This department will ... 1,677 1,929 Other long term assets 1,387 1,664 Total long term assets 3,641 3,674 ...

Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007

... optional and mandatory principal repayments of term debt totaling $350.5 million using free cash flow ... FINANCING ACTIVITIES: Borrowings under bank term credit facility - ... (Repayments) under senior secured credit term loan facility (92,305) ...

US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results

... In this release, the Company uses the term "EBITDA" and "Adjusted EBITDA". EBITDA is ... 413,232 - Proceeds from term loan - ... (256,766) - Repayment of term loan (7,487) ...

Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%

... from the Board following completion of his term of office. In October 2007 David Mott joined ... River which was partly funded by $1.3 billion of term loans, utilized under the $2.3 billion Multicurrency Term and Revolving Facilities Agreement. These term loans were subsequently partially repaid using ...

Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007

... 52,056 Deferred income tax - short term 8,825 7,247 Prepaid ... 18,621 18,621 Deferred income tax - long term 7,942 2,064 License, ... 3,958 - Deferred income tax - long term 75 - Deferred ...

Millennium Over-Delivers on 2007 Goals and Financial Guidance

... $125,948 Current portion of long term debt - 99,571 Other long term liabilities 43,337 ... 73,795 75,041 Long term debt, net of current portion 250,000 ...

Hologic Announces First Quarter Fiscal 2008 Operating Results

... of convertible senior notes (at 2% interest). -- term loan balance reduced to $295 million at December ... the Company's ThinPrep products and Full term Fetal Fibronectin test, totaled $100.3 million ... 9,985 10,135 Other long term liabilities 49,357 ...

MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results

... no increase in reported diarrhea with long term treatment, nor an increase in incidence and ... a renewal option for an additional three- year term and rights of first offer for approximately 1,200 ... $29.5 million) over the estimated royalty payment term using the effective interest method; and (ii) ...

China Medical Technologies Reports Second Quarter Financial Results

... with the present value discounting of long term other payable of US$10 million for the ... The issuance cost is amortized over the five year term of the convertible notes. Income tax expense was ... 1,123,920 150,000 Other payable - long term 67,206 67,794 67,902 9,062 ...

China Biologic Products Reports Record Third Quarter 2007 Results

... 920,083 718,011 Long term deferred assets 727 ... 2,062,683 1,874,973 Short term loans - bank 1,334,000 2,564,000 Short term loan - minority shareholder ...

Alexandria Real Estate Equities, Inc. Reports Third Quarter 2007 Results

... payable, unsecured line of credit and unsecured term loan and unsecured convertible notes) to ... Unsecured line of credit and unsecured term loan 880,000 ... an additional one year period. The unsecured term loan matures in October 2011 and may be extended ...
Other Contents
(Date:7/9/2014)... injuries have identified an immune marker that predicts ... infection. The study, led by clinician-scientists at Nationwide ... the journal Shock , is part of ... clinical implementation of quick-turnaround immune function tests and ... following critical illness or injury in pediatric patients. ...
(Date:7/9/2014)... co-authored by a University of Guelph scientist that ... shows long-term exposure to a neonicotinoid pesticide hampers ... research by Nigel Raine, a professor in Guelph,s ... Imperial College London was published July 9 in ... . , The study shows how long-term pesticide ...
(Date:7/9/2014)... With over 100 diseases that can attack soybean crops, ... the most wanted list? University of Illinois scientists cite ... research is needed on the fungus that causes charcoal ... damp growing conditions but Macrophomina phaseolina , the ... drought conditions. , "As the climate continues to change ...
Breaking Biology News(10 mins):Immune function predicts infection risk among child trauma patients 2Immune function predicts infection risk among child trauma patients 3Bee foraging chronically impaired by pesticide exposure: Study 2Climate change provides good growing conditions for charcoal rot in soybeans 2Climate change provides good growing conditions for charcoal rot in soybeans 3
(Date:7/10/2014)... The benefits of medical imaging far outweigh the ... Right Way, with The Right Radiation Dose. However, overuse ... Mayo Clinic is leading a collaborative effort to ensure ... published online in the Journal of Patient Safety ... Joint Commission, the Intersociety Accreditation Commission, and the Centers ...
(Date:7/10/2014)... For decades, health-conscious people around the globe have ... figuring this was one of the paths to good ... clinical trials of antioxidant supplements have repeatedly dashed the ... their cancer risk. Virtually all such trials have ... In fact, in several trials antioxidant supplementation has been ...
(Date:7/10/2014)... Men who experience hot flashes are unlikely to ... from their silent suffering if they are willing ... a Baylor University case study., After seven weeks of ... hot flashes following prostate cancer surgery showed a drastic ... impressive improvement in sleep quality, according to the study., ...
(Date:7/9/2014)... MA -- Vasectomy was associated with a small increased ... advanced or lethal prostate cancer according to a new ... researchers found that the association remained even among men ... of lethal cancer cannot be explained by diagnostic bias. ... date to look at the link between vasectomy and ...
(Date:7/9/2014)... cancer, researchers have uncovered mutations in a cell-signaling pathway ... knowledge may expand treatments for patients because drugs targeting ... are in clinical trials. , Reporting July 9 in ... (TCGA), including researchers at Washington University School of Medicine ... studied tumors from 230 patients with lung adenocarcinoma. , ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic calls for standardization of safe imaging protocols for children 2Health News:How antioxidants can accelerate cancers, and why they don't protect against them 2Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 2Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 3Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 4Health News:Vasectomy may increase risk of aggressive prostate cancer 2Health News:Lung cancer study hints at new treatments 2
Other TagsOther Tags